Sign Up to like & get
recommendations!
0
Published in 2017 at "Molecular Oncology"
DOI: 10.1002/1878-0261.12076
Abstract: The multikinase inhibitor and FDA‐approved drug dovitinib (Dov) crosses the blood–brain barrier and was recently used as single drug application in clinical trials for GB patients with recurrent disease. The Dov‐mediated molecular mechanisms in GB…
read more here.
Keywords:
enhances temozolomide;
treatment;
dov;
dovitinib enhances ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "OncoTargets and therapy"
DOI: 10.2147/ott.s193911
Abstract: [This corrects the article on p. 5429 in vol. 11, PMID: 30233204.].
read more here.
Keywords:
borneol novel;
temozolomide induced;
natural borneol;
enhances temozolomide ... See more keywords